Ikenberg R, Hertel N, Moore RA, et al. Cost-effectiveness of tapentadol prolonged release compared with oxycodone controlled release in the UK in patients with severe non-malignant chronic pain who failed 1st line treatment with morphine [published correction appears in J Med Econ. 2012;15(6):1216]. J Med Econ. 2012;15(4):724-736. doi:10.3111/13696998.2012.670174

Leave a Reply